These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 4094634)

  • 1. [Is aluminum poisoning unavoidable in the uremic patient?].
    Drüeke T; Rottembourg J
    Nephrologie; 1985; 6(5):217-8. PubMed ID: 4094634
    [No Abstract]   [Full Text] [Related]  

  • 2. [Practical considerations on aluminum hazards in uremic patients on dialysis].
    Gilli P; Malacarne F
    Minerva Nefrol; 1982; 29(4):233-4. PubMed ID: 7155444
    [No Abstract]   [Full Text] [Related]  

  • 3. [Aluminium poisoning in uremic children].
    Hinojosa-Lezama M; Gordillo-Paniagua G
    Bol Med Hosp Infant Mex; 1986 Sep; 43(9):532-6. PubMed ID: 3790225
    [No Abstract]   [Full Text] [Related]  

  • 4. Aluminum, vanadium, and lead intoxication of uremic patients undergoing hemodialysis in Venezuela.
    Romero RA
    Transplant Proc; 1994 Feb; 26(1):330-2. PubMed ID: 8109003
    [No Abstract]   [Full Text] [Related]  

  • 5. Iatrogenic aluminum poisoning.
    Savory J
    Clin Chem; 1994 Aug; 40(8):1477-8. PubMed ID: 8044984
    [No Abstract]   [Full Text] [Related]  

  • 6. Dialysis encephalopathy.
    Alfrey AC
    Kidney Int Suppl; 1986 Feb; 18():S53-7. PubMed ID: 3457997
    [No Abstract]   [Full Text] [Related]  

  • 7. Aluminum and iron overload in chronic dialysis.
    Ackrill P; Day JP; Ahmed R
    Kidney Int Suppl; 1988 Mar; 24():S163-7. PubMed ID: 3283407
    [No Abstract]   [Full Text] [Related]  

  • 8. Deferoxamine (DFO): the effectiveness for noninvasive diagnosis of aluminum-related bone disease, and for treatment of the disease.
    Marumo F; Umetani N; Sato N; Takahashi Y
    J UOEH; 1987 Mar; 9 Suppl():140-52. PubMed ID: 3602745
    [No Abstract]   [Full Text] [Related]  

  • 9. Acute fatal hyperaluminemic encephalopathy in undialyzed and recently dialyzed uremic patients.
    Bakir AA; Hryhorczuk DO; Berman E; Dunea G
    ASAIO Trans; 1986; 32(1):171-6. PubMed ID: 3778707
    [No Abstract]   [Full Text] [Related]  

  • 10. [Osteomalacia as a result of aluminum poisoning during chronic hemodialysis].
    Cournot-Witmer G; Gagnadoux MF; Lebon P; Broyer M; Balsan S
    Arch Fr Pediatr; 1982 Dec; 39 Suppl 2():749-54. PubMed ID: 6762177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of aluminum on hematopoiesis.
    Drüeke TB; Lacour B; Touam M; Jucquel JP; Plachot JJ; Cournot-Witmer G; Galle P
    Kidney Int Suppl; 1986 Feb; 18():S45-8. PubMed ID: 3457995
    [No Abstract]   [Full Text] [Related]  

  • 12. [Uremic encephalopathy, dialysis encephalopathy].
    Kinugasa E
    Nihon Rinsho; 2004 Jan; 62 Suppl():424-8. PubMed ID: 15011399
    [No Abstract]   [Full Text] [Related]  

  • 13. [Development of dialysis encephalopathy in the context of rubidium and aluminum levels in the blood and cerebral cortex of patients with concomitant uremic polyneuropathy on long-term dialysis].
    Adamiec R; Uzar J
    Przegl Lek; 1987; 44(3):309-14. PubMed ID: 3615935
    [No Abstract]   [Full Text] [Related]  

  • 14. Aluminum an uremic toxin.
    D'Haese PC; Van de Vyver FL; Lamberts LV; De Broe ME
    Adv Exp Med Biol; 1987; 223():89-96. PubMed ID: 3447454
    [No Abstract]   [Full Text] [Related]  

  • 15. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aluminum metabolism.
    Alfrey AC
    Kidney Int Suppl; 1986 Feb; 18():S8-11. PubMed ID: 3458002
    [No Abstract]   [Full Text] [Related]  

  • 17. Aluminum-induced osteomalacia: an explanation.
    Thomas WC; Meyer JL
    Am J Nephrol; 1984; 4(3):201-3. PubMed ID: 6742013
    [No Abstract]   [Full Text] [Related]  

  • 18. Aluminum and renal disease.
    Alfrey AC
    Contrib Nephrol; 1993; 102():110-24. PubMed ID: 8416176
    [No Abstract]   [Full Text] [Related]  

  • 19. 1 alpha(OH) vitamin D3 increases plasma aluminum in hemodialyzed patients taking Al(OH)3.
    Demontis R; Westeel PF; Boudalliez B; Moriniere P; Leflon A; Abdulmassih Z; Atik H; Renaud H; Fournier A
    Kidney Int Suppl; 1988 Mar; 24():S175-7. PubMed ID: 3163043
    [No Abstract]   [Full Text] [Related]  

  • 20. Assessment of the aluminum overload and of its possible toxicity in asymptomatic uremic patients: evidence for a depressive effect on bone formation.
    Sebert JL; Marie A; Gueris J; Herve MA; Leflon P; Garabedian M; Smadja A; Fournier A
    Bone; 1985; 6(5):373-5. PubMed ID: 4096874
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.